Sun Pharma, EMS ready binding bids for Medley
Sale process of Brazilian pharma enters decisive phase as final offers are expected between late February and early March 01/29/2026 India’s Sun Pharma and Brazil’s EMS are seen as the leading contenders to acquire Medley, the generic-drug maker owned by France’s Sanofi. Other domestic companies are also in the running, including Aché, Biolab and Hypera, […]
